These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8658619)

  • 1. Immunopathogenesis of GVHD.
    Imamura M; Tanaka J; Hashino S; Kobayashi S; Imai K; Asaka M; Kasai M
    Transplant Proc; 1996 Jun; 28(3):1181-3. PubMed ID: 8658619
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytokine storm of graft-versus-host disease: a critical effector role for interleukin-1.
    Ferrara JL; Abhyankar S; Gilliland DG
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1216-7. PubMed ID: 8442093
    [No Abstract]   [Full Text] [Related]  

  • 3. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
    Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
    Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allospecific CD8+ Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease.
    Fowler DH; Breglio J; Nagel G; Eckhaus MA; Gress RE
    J Immunol; 1996 Dec; 157(11):4811-21. PubMed ID: 8943383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
    Asai O; Longo DL; Tian ZG; Hornung RL; Taub DD; Ruscetti FW; Murphy WJ
    J Clin Invest; 1998 May; 101(9):1835-42. PubMed ID: 9576746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of new immune cells reveals reason for rejection of bone marrow grafts.
    Oncology (Williston Park); 1990 Apr; 4(4):132, 137. PubMed ID: 2143922
    [No Abstract]   [Full Text] [Related]  

  • 7. Facilitation of parental-strain marrow engraftment by T cells of neonatally-tolerant mice.
    Davenport C; George T; Devora GA; Morris MA; Gordon BE; Kumar V; Bennett M
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):294-303. PubMed ID: 9502296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermediate TCR cells can induce graft-versus-host disease after allogeneic bone marrow transplantation.
    Weerasinghe A; Kawamura T; Moroda T; Seki S; Watanabe H; Abo T
    Cell Immunol; 1998 Apr; 185(1):14-29. PubMed ID: 9636679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporine-induced autologous graft versus host disease: assessment of cytolytic effector mechanisms and the V beta T-cell receptor repertoire.
    Ruvolo P; Bright E; Kennedy MJ; Morris L; Fischer A; Vogelsang G; Jones R; Hess A
    Transplant Proc; 1995 Feb; 27(1):1363-5. PubMed ID: 7878913
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytokine network in peripheral blood mononuclear cells after allogeneic bone marrow transplantation.
    Tanaka J; Imamura M; Kasai M; Hashino S; Kobayashi S; Noto S; Sakurada K; Asaka M
    Transplant Proc; 1996 Jun; 28(3):1746-7. PubMed ID: 8658865
    [No Abstract]   [Full Text] [Related]  

  • 11. Antigen-specific T-lymphocyte responses in acute and chronic syngeneic graft-versus-host disease.
    Hess AD; Thoburn CJ; Miura Y; Bright EC
    Transplant Proc; 2005; 37(1):53-6. PubMed ID: 15808545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FTY720 enhances the activation-induced apoptosis of donor T cells and modulates graft-versus-host disease.
    Hashimoto D; Asakura S; Matsuoka K; Sakoda Y; Koyama M; Aoyama K; Tanimoto M; Teshima T
    Eur J Immunol; 2007 Jan; 37(1):271-81. PubMed ID: 17154260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment.
    Drobyski WR; Majewski D; Ozker K; Hanson G
    J Immunol; 1998 Sep; 161(5):2610-9. PubMed ID: 9725263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapamycin inhibits the generation of graft-versus-host disease- and graft-versus-leukemia-causing T cells by interfering with the production of Th1 or Th1 cytotoxic cytokines.
    Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Vallera DA
    J Immunol; 1998 Jun; 160(11):5355-65. PubMed ID: 9605135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adoptive transfer of small numbers of DX5+ cells alleviates graft-versus-host disease in a murine model of semiallogeneic bone marrow transplantation: a potential role for NKT lymphocytes.
    Margalit M; Ilan Y; Ohana M; Safadi R; Alper R; Sherman Y; Doviner V; Rabbani E; Engelhardt D; Nagler A
    Bone Marrow Transplant; 2005 Jan; 35(2):191-7. PubMed ID: 15558045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graft-versus-host disease: liver morphology and pheno/genotypes of inflammatory cells and target cells in sex-mismatched allogeneic bone marrow transplant patients.
    Andersen CB; Horn T; Sehested M; Junge J; Jacobsen N
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1250-4. PubMed ID: 8442105
    [No Abstract]   [Full Text] [Related]  

  • 17. PD-1-PD-L1 pathway is involved in suppressing alloreactivity of heart infiltrating t cells during murine gvhd across minor histocompatibility antigen barriers.
    Schilbach K; Schick J; Wehrmann M; Wollny G; Simon P; Schlegel PG; Eyrich M
    Transplantation; 2007 Jul; 84(2):214-22. PubMed ID: 17667813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants.
    Ruggeri L; Capanni M; Urbani E; Perruccio K; Shlomchik WD; Tosti A; Posati S; Rogaia D; Frassoni F; Aversa F; Martelli MF; Velardi A
    Science; 2002 Mar; 295(5562):2097-100. PubMed ID: 11896281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A two-phase pathogenesis of graft-versus-host disease in mice.
    van Leeuwen L; Guiffre A; Atkinson K; Rainer SP; Sewell WA
    Bone Marrow Transplant; 2002 Jan; 29(2):151-8. PubMed ID: 11850710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.